SIGHT SCIENCES INC (SGHT) — insider trading
Health Care · NASDAQ
SIGHT SCIENCES INC (SGHT) has 25 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 18 open-market sales among the most recent 25 (latest 2026-10-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton | Officer (EVP, Operations & R&D) | Open-market sale | 2,988 | $8.85 | $26.5K | Form 4 |
| 2026-10-02 | Rodberg James | Officer (Chief Financial Officer) | Open-market sale | 7,208 | $8.85 | $63.8K | Form 4 |
| 2026-10-02 | Bauerlein Alison | Officer (Chief Operating Officer) | Open-market sale | 25,260 | $8.85 | $223.6K | Form 4 |
| 2026-10-01 | Badawi Paul | Director, Officer (President and CEO), 10% owner | Open-market sale | 29,653 | $9.05 | $268.3K | Form 4 |
| 2026-10-01 | Badawi David | Director, Officer (Chief Technology Officer) | Open-market sale | 7,797 | $9.05 | $70.6K | Form 4 |
| 2026-08-10 | Rashid Kashif | Officer (Chief Legal Officer) | Grant / award / vesting | 181,818 | — | $0 | Form 4 |
| 2026-07-06 | Badawi David | Director, Officer (Chief Technology Officer) | Open-market sale | 7,418 | $5.51 | $40.9K | Form 4 |
| 2026-07-06 | HAYDEN JEREMY B. | Officer (Chief Legal Officer) | Open-market sale | 12,733 | $5.51 | $70.1K | Form 4 |
| 2026-07-02 | Bauerlein Alison | Officer (Chief Operating Officer) | Open-market sale | 24,184 | $5.36 | $129.6K | Form 4 |
| 2026-07-02 | Rodberg James | Officer (Chief Financial Officer) | Open-market sale | 6,902 | $5.36 | $37.0K | Form 4 |
| 2026-07-01 | Badawi Paul | Director, Officer (President and CEO), 10% owner | Open-market sale | 28,684 | $5.42 | $155.5K | Form 4 |
| 2026-07-01 | Taylor Brenton | Officer (EVP, Operations & R&D) | Open-market sale | 2,829 | $5.42 | $15.3K | Form 4 |
| 2026-06-10 | Encrantz Staffan | Director, 10% owner | Open-market purchase | 14,100 | $4.88 | $68.8K | Form 4 |
| 2026-06-04 | Mazzacco Catherine | Director | Grant / award / vesting | 28,261 | — | $0 | Form 4 |
| 2026-06-04 | Zurbay Donald | Director | Grant / award / vesting | 28,261 | — | $0 | Form 4 |
| 2026-06-04 | Burbach Gerhard F | Director | Grant / award / vesting | 28,261 | — | $0 | Form 4 |
| 2026-06-04 | Encrantz Staffan | Director, 10% owner | Grant / award / vesting | 28,261 | — | $0 | Form 4 |
| 2026-06-04 | Fountain Tamara | Director | Grant / award / vesting | 28,261 | — | $0 | Form 4 |
| 2026-05-18 | Bauerlein Alison | Officer (Chief Operating Officer) | Open-market sale | 12,728 | $5.12 | $65.2K | Form 4 |
| 2026-04-06 | HAYDEN JEREMY B. | Officer (Chief Legal Officer) | Open-market sale | 13,761 | $3.55 | $48.9K | Form 4 |
| 2026-04-06 | Rodberg James | Officer (Chief Financial Officer) | Open-market sale | 7,231 | $3.55 | $25.7K | Form 4 |
| 2026-04-02 | Badawi David | Director, Officer (Chief Technology Officer) | Open-market sale | 8,168 | $3.48 | $28.4K | Form 4 |
| 2026-04-02 | Bauerlein Alison | Officer (Chief Operating Officer) | Open-market sale | 25,874 | $3.48 | $90.0K | Form 4 |
| 2026-04-01 | Badawi Paul | Director, Officer (President and CEO), 10% owner | Open-market sale | 29,244 | $3.70 | $108.2K | Form 4 |
| 2026-04-01 | Taylor Brenton | Officer (EVP, Operations & R&D) | Open-market sale | 2,869 | $3.70 | $10.6K | Form 4 |
Ask the chat about SGHT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SIGHT SCIENCES INC (SGHT).
Last updated 2026-10-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.